全文获取类型
收费全文 | 251503篇 |
免费 | 17327篇 |
国内免费 | 1242篇 |
专业分类
耳鼻咽喉 | 2867篇 |
儿科学 | 6251篇 |
妇产科学 | 4605篇 |
基础医学 | 31734篇 |
口腔科学 | 5506篇 |
临床医学 | 25676篇 |
内科学 | 53816篇 |
皮肤病学 | 3599篇 |
神经病学 | 23471篇 |
特种医学 | 9476篇 |
外国民族医学 | 6篇 |
外科学 | 40654篇 |
综合类 | 2826篇 |
现状与发展 | 1篇 |
一般理论 | 420篇 |
预防医学 | 19478篇 |
眼科学 | 5598篇 |
药学 | 16254篇 |
中国医学 | 377篇 |
肿瘤学 | 17457篇 |
出版年
2023年 | 1477篇 |
2022年 | 2373篇 |
2021年 | 6300篇 |
2020年 | 3718篇 |
2019年 | 5727篇 |
2018年 | 6844篇 |
2017年 | 4843篇 |
2016年 | 5317篇 |
2015年 | 6052篇 |
2014年 | 8867篇 |
2013年 | 12182篇 |
2012年 | 18370篇 |
2011年 | 19116篇 |
2010年 | 10843篇 |
2009年 | 9718篇 |
2008年 | 16934篇 |
2007年 | 17235篇 |
2006年 | 16614篇 |
2005年 | 16310篇 |
2004年 | 15308篇 |
2003年 | 13862篇 |
2002年 | 13039篇 |
2001年 | 2126篇 |
2000年 | 1640篇 |
1999年 | 2237篇 |
1998年 | 2782篇 |
1997年 | 2192篇 |
1996年 | 1772篇 |
1995年 | 1703篇 |
1994年 | 1468篇 |
1993年 | 1449篇 |
1992年 | 1310篇 |
1991年 | 1217篇 |
1990年 | 1023篇 |
1989年 | 999篇 |
1988年 | 946篇 |
1987年 | 900篇 |
1986年 | 872篇 |
1985年 | 973篇 |
1984年 | 1077篇 |
1983年 | 941篇 |
1982年 | 1188篇 |
1981年 | 1046篇 |
1980年 | 954篇 |
1979年 | 542篇 |
1978年 | 626篇 |
1977年 | 598篇 |
1976年 | 466篇 |
1975年 | 480篇 |
1974年 | 433篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
3.
4.
Georg Prokop Benedikt Wiestler Daniel Hieber Fynn Withake Karoline Mayer Jens Gempt Claire Delbridge Friederike Schmidt-Graf Nicole Pfarr Bruno Märkl Jürgen Schlegel Friederike Liesche-Starnecker 《International journal of cancer. Journal international du cancer》2023,153(9):1658-1670
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered. 相似文献
5.
6.
Rajendrababu Sharmila Puthuran George Varghese Alia Laxmi Ananya Uduman Mohammed Sithiq Wijesinghe Hiruni Kaushalya 《International ophthalmology》2022,42(8):2609-2618
International Ophthalmology - To investigate the efficacy and safety of non-valved Aurolab aqueous drainage implant (AADI) surgery combined with phacoemulsification in eyes with refractory glaucoma... 相似文献
7.
8.
9.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
10.